Supriya Lifescience has inaugurated a state-of-the-art multipurpose active pharmaceutical ingredient (API) production block at its Lote Parshuram site in Maharashtra.
Located in Module E, the facility represents a significant milestone in the company’s growth journey, developed with an investment of approximately ₹120 crore.
Capacity Boost and Enhanced Infrastructure
The production block significantly expands the site’s capacity from 597 kilo liters per day (KLPD) to 932 KLPD. The facility spans 5,000 square meters and structures itself over four levels. It is designed to ensure efficient operations and safe workflows. It includes 33 reactors, comprising stainless steel and glass-lined types, with capacities ranging from 1.6 KL to 16 KL.
Focus on Innovation and R&D
The facility underscores Supriya’s commitment to innovation. It supports efforts to enhance research and development capabilities and scale up its pipeline of cutting-edge products.
The block will facilitate the commercialization of innovative APIs in niche therapeutic segments, further solidifying the company’s presence in key global markets.
Strengthening Backward Integration Model
Designed to align with Supriya’s backward integration strategy, the facility helps the company achieve economies of scale. This ensures it maintains a competitive edge.
By consolidating its production processes, Supriya aims to streamline operations and optimize resource utilization effectively.
Expanding Global Reach
This expansion positions Supriya Lifescience to strengthen its role in the pharmaceutical industry. The company aims to better serve its existing markets and explore new geographies.
As reported by projectstoday.com, the strategic investment highlights the company’s vision of sustainable growth and innovation-driven success.
